Filing Details
- Accession Number:
- 0001209191-18-007272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-02 20:25:13
- Reporting Period:
- 2018-01-31
- Accepted Time:
- 2018-02-02 20:25:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408920 | T Joseph Kennedy | C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-01-31 | 60,937 | $0.00 | 60,937 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-01-31 | 26,667 | $0.00 | 87,604 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-01-31 | 36,000 | $0.00 | 123,604 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-01-31 | 60,313 | $3.83 | 63,291 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2018-01-31 | 44,857 | $3.73 | 18,434 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2018-01-31 | 60,937 | $0.00 | 60,937 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2018-01-31 | 26,667 | $0.00 | 26,667 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2018-01-31 | 36,000 | $0.00 | 36,000 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Acquisiton | 2018-02-01 | 78,000 | $0.00 | 78,000 | $0.00 |
| Ordinary Shares | Stock Option (Right to Buy) | Acquisiton | 2018-02-01 | 117,000 | $3.80 | 117,000 | $3.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 26,666 | No | 4 | M | Direct | ||
| 72,000 | No | 4 | M | Direct | ||
| 78,000 | No | 4 | A | Direct | ||
| 117,000 | 2028-02-01 | No | 4 | A | Direct |
Footnotes
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- On February 2, 2015, the Reporting Person was granted 182,813 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2016, January 31, 2017 and January 31, 2018. The third and final vesting event occurred on January 31, 2018.
- Not applicable.
- On February 1, 2016, the Reporting Person was granted 80,000 RSUs under the Amarin Corporation plc 2011 Stock Inventive Plan. These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The second vesting event occurred on January 31, 2018.
- On February 1, 2017, the Reporting Person was granted 108,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The first vesting event occurred on January 31, 2018.
- Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
- Sales made pursuant to a 10b5-1 trading plan dated December 9, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
- Please see the section titled "Remarks" below for additional information.
- On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021.
- On February 1, 2018, the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018.
Billionaire Hedge Funds
